obstructive sleep apnea syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-60 years; 2. Snoring more than 5 days a week, and repeatedly hold the breath or open the mouth to breathe during sleep; 3. OSA patients with 0-2 degrees Friedman tonsils and 1-2 degrees Friedman tongue position diagnosed by laboratory standard polysomnography; 4. Willing to use nasal cavity devices, voluntarily participate in this clinical study, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant women; 2. Patients with nasal polyps and nasal ventilation disorders; patients with nasal bleeding or bleeding tendency; patients with nasal trauma, nasal cavity deformity, infection or wound in the nasal cavity; patients with severe nasal septum, nasal obstruction, fractures and skull base fractures; patients with cerebrospinal fluid rhinorrhea ; Patients with coagulopathy (risk of nose bleeding); 3. Cardio-cerebrovascular diseases (hypertension, recurrent atrial fibrillation, left heart failure, coronary artery disease and stroke); respiratory diseases (respiratory failure, COPD); mental and neurological diseases (epilepsy); advanced cancer and chronic inflammatory diseases; 4. Silicone allergy (the nasopharyngeal airway used in this study contains this ingredient); 5. Acute upper respiratory tract infection; 6. The investigator believes that there are any reasons not suitable for participating in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AHI index and lowest oxygen saturation; | — |
Secondary
| Measure | Time frame |
|---|---|
| physical index;usage time;blood test index; | — |
Countries
China
Contacts
The Sixth People's Hospital affiliated to Shanghai Jiao Tong University